Browse studies

Find your next paid study

1 recruiting study matching your filters

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus

Background: People with systemic lupus erythematosus (SLE) are at risk of developing complications in their blood vessels. This can increase the risk of heart…

Systemic Lupus ErythematosusCardiovascular DiseasePremature Atherosclerosis

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NCT05440422